Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2038 (LINC02038) is a long non-coding RNA located on chromosome 3, classified as an intergenic lncRNA[3][5][7]. LINC02038 is downregulated in colorectal cancer tissues and cell lines compared to normal tissues, and its overexpression suppresses proliferation, migration, and invasion of colorectal cancer cells while promoting apoptosis[2]. Functionally, LINC02038 acts mainly in the cytoplasm as a molecular sponge (competing endogenous RNA) for microRNA miR-552-5p, preventing it from downregulating its target, FAM172A, thus modulating tumor-related signaling such as PI3K/AKT[2][6]. LINC02038’s tumor-suppressor role and its significant association with poor prognosis in colorectal cancer suggest its potential utility as a prognostic biomarker[2]. However, there are currently no known drugs or therapies that directly target LINC02038, and it is not considered a canonical therapeutic target such as a receptor, enzyme, or transporter[2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2038 (LINC02038).